RA
BVS icon

Royce & Associates’s Bioventus BVS Stock Holding History

Royce & Associates’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3M Buy
1,833,212
+291,930
+19% +$2.79M 0.14% 243
2026
Q1 		$14.1M Buy
1,541,282
+290,000
+23% +$2.43M 0.14% 240
2025
Q4 		$9.31M Sell
1,251,282
-11,694
-0.9% -$84.1K 0.09% 332
2025
Q3 		$8.45M Buy
1,262,976
+170,900
+16% +$1.19M 0.08% 356
2025
Q2 		$7.23M Buy
1,092,076
+199,860
+22% +$1.42M 0.07% 385
2025
Q1 		$8.16M Buy
892,216
+159,980
+22% +$1.6M 0.09% 333
2024
Q4 		$7.69M Buy
732,236
+34,540
+5% +$409K 0.07% 396
2024
Q3 		$8.34M Buy
+697,696
New +$6.03M 0.08% 361
2023
Q4 		– Sell
-50,000
Closed -$165K – 871
2023
Q3 		$165K Hold
50,000
– – ﹤0.01% 883
2023
Q2 		$145K Hold
50,000
– – ﹤0.01% 891
2023
Q1 		$53.5K Sell
50,000
-191,306
-79% -$366K ﹤0.01% 906
2022
Q4 		$630K Sell
241,306
-1,854,879
-88% -$8.1M 0.01% 806
2022
Q3 		$14.7M Buy
2,096,185
+137,400
+7% +$1.08M 0.17% 165
2022
Q2 		$13.4M Buy
1,958,785
+15,602
+0.8% +$159K 0.14% 214
2022
Q1 		$27.4M Buy
1,943,183
+154,978
+9% +$2.07M 0.23% 105
2021
Q4 		$25.9M Buy
+1,788,205
New +$25.4M 0.19% 145

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Royce & Associates's BVS Position: Q2 2026 in Review

Royce & Associates increased its Bioventus (BVS) stake by 19% in Q2 2026, buying an estimated $2.79M and bringing the position to 1,833,212 shares worth $17.3M. The position accounts for 0.14% of the portfolio, ranked #243.

Royce & Associates first reported a position in BVS in Q4 2021 and has held it in 16 quarters since. The position peaked at $27.4M in Q1 2022. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Royce & Associates held 1,833,212 shares of Bioventus worth $17.3M as of Q2 2026.
  • Royce & Associates bought 291,930 Bioventus shares in Q2 2026, an estimated $2.79M.
  • Bioventus made up 0.14% of Royce & Associates's portfolio in Q2 2026, its #243 holding.
  • Royce & Associates first reported a position in Bioventus in Q4 2021 and has held it in 16 quarters since.
  • Royce & Associates's Bioventus position peaked at $27.4M in Q1 2022.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.